Icon for Silverchair Information Systems Icon for PubMed Central Related Articles

novoPathFinder: a webserver of designing novel-pathway with integrating GEM-model.

Nucleic Acids Res. 2020 07 02;48(W1):W477-W487

Authors: Ding S, Tian Y, Cai P, Zhang D, Cheng X, Sun D, Yuan L, Chen J, Tu W, Wei DQ, Hu QN

To increase the number of value-added chemicals that can be produced by metabolic engineering and synthetic biology, constructing metabolic space with novel reactions/pathways is crucial. However, with the large number of reactions that existed in the metabolic space and complicated metabolisms within hosts, identifying novel pathways linking two molecules or heterologous pathways when engineering a host to produce a target molecule is an arduous task. Hence, we built a user-friendly web server, novoPathFinder, which has several features: (i) enumerate novel pathways between two specified molecules without considering hosts; (ii) construct heterologous pathways with known or putative reactions for producing target molecule within Escherichia coli or yeast without giving precursor; (iii) estimate novel pathways with considering several categories, including enzyme promiscuity, Synthetic Complex Score (SCScore) and LD50 of intermediates, overall stoichiometric conversions, pathway length, theoretical yields and thermodynamic feasibility. According to the results, novoPathFinder is more capable to recover experimentally validated pathways when comparing other rule-based web server tools. Besides, more efficient pathways with novel reactions could also be retrieved for further experimental exploration. novoPathFinder is available at http://design.rxnfinder.org/novopathfinder/.

PMID: 32313937 [PubMed – indexed for MEDLINE]

Source: ncbi

Partage le savoir
Categories: Medical

error: Content is protected !!